Synageva BioPharma Corp. , a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced its presentation at the upcoming Cowen and Company 33rd Annual Health Care Conference.
http://www.businesswire.com/news/topix/20130226006404/en
http://www.businesswire.com/news/topix/20130226006404/en
No comments:
Post a Comment